Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Daily Top 10 COVID-19 papers DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM

Ischemic Heart Disease

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 172 articles: HTML format

Single Articles

May 2020
1. DE ROSA S, Spaccarotella C, Basso C, Calabro MP, et al
   Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.
   Eur Heart J. 2020 May 15. pii: 5837572. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. CHIEFFO A, Stefanini GG, Price S, Barbato E, et al
   EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic.
   Eur Heart J. 2020;41:1839-1851.
   PubMed     Abstract available
   
   
   
3. METZLER B, Siostrzonek P, Binder RK, Bauer A, et al
   Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage.
   Eur Heart J. 2020;41:1852-1853.
   PubMed    
   
   
   
4. CAMPO G, Rapezzi C, Tavazzi L, Ferrari R, et al
   Priorities for Cath labs in the COVID-19 tsunami.
   Eur Heart J. 2020;41:1784-1785.
   PubMed    
   
   
   
5. SHAH R
   Accuracy of fractional flow reserve during acute myocardial infarction.
   Eur Heart J. 2020 May 8. pii: 5834910. doi: 10.1093.
   PubMed    
   
   
   
6. UEKI Y, Otsuka T, Windecker S, Raber L, et al
   ST-elevation myocardial infarction and pulmonary embolism in a patient with COVID-19 acute respiratory distress syndrome.
   Eur Heart J. 2020 May 6. pii: 5831090. doi: 10.1093.
   PubMed    
   
   
   
7. GAUDINO M, Freemantle N, Farkouh ME
   The conundrum of the treatment for left main coronary disease.
   Eur Heart J. 2020 May 5. pii: 5830808. doi: 10.1093.
   PubMed    
   
   
   April 2020
8. DREXLER M, Elsner C, Gabelmann V, Gori T, et al
   Apple Watch detecting coronary ischaemia during chest pain episodes or an apple a day may keep myocardial infarction away.
   Eur Heart J. 2020 Apr 29. pii: 5826159. doi: 10.1093.
   PubMed    
   
   
   
9. HAN Y
   A treatment strategy for acute myocardial infarction and personal protection for medical staff during the COVID-19 epidemic: the Chinese experience.
   Eur Heart J. 2020 Apr 27. pii: 5825637. doi: 10.1093.
   PubMed    
   
   
   
10. ZULLO A, Lorenzetti R, Hassan C
    Is Escherichia coli involved in the myocardial infarction?
    Eur Heart J. 2020 Apr 16. pii: 5821041. doi: 10.1093.
    PubMed    
    
    
    
11. VIOLI F, Nocella C, Carnevale R
    Gut microbiota and myocardial infarction.
    Eur Heart J. 2020 Apr 16. pii: 5821053. doi: 10.1093.
    PubMed    
    
    
    
12. CHATTERJEE NA, Tikkanen JT, Panicker GK, Narula D, et al
    Simple electrocardiographic measures improve sudden arrhythmic death prediction in coronary disease.
    Eur Heart J. 2020 Apr 7. pii: 5817075. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2020
13. JING ZC, Zhu HD, Yan XW, Chai WZ, et al
    Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak.
    Eur Heart J. 2020 Mar 31. pii: 5813956. doi: 10.1093.
    PubMed    
    
    
    
14. STONE GW, Ben-Yehuda O, Sabik JF, Kappetein AP, et al
    Considerations for an optimal definition of procedural myocardial infarction.
    Eur Heart J. 2020 Mar 30. pii: 5813684. doi: 10.1093.
    PubMed    
    
    
    
15. BOHM M, Ferreira JP, Mahfoud F, Duarte K, et al
    Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial.
    Eur Heart J. 2020 Mar 2. pii: 5771273. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2020
16. HARTIKAINEN TS, Sorensen NA, Haller PM, Gossling A, et al
    Clinical application of the 4th Universal Definition of Myocardial Infarction.
    Eur Heart J. 2020 Feb 20. pii: 5741381. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. ALLAHYARI A, Jernberg T, Hagstrom E, Leosdottir M, et al
    Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study.
    Eur Heart J. 2020 Feb 18. pii: 5739477. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. RYMER JA, Granger CB
    Managing patients with ST-elevation myocardial infarction and multivessel disease: is the story complete?
    Eur Heart J. 2020 Feb 7. pii: 5729984. doi: 10.1093.
    PubMed    
    
    
    
19. RAMASAMY A, Bajaj R, Choudry FA, Pugliese F, et al
    Intravascular ultrasound-guided management of ST-elevation myocardial infarction in a patient with lung cancer and myocardial metastasis.
    Eur Heart J. 2020 Feb 7. pii: 5729982. doi: 10.1093.
    PubMed    
    
    
    January 2020
20. CARNEVALE R, Sciarretta S, Valenti V, di Nonno F, et al
    Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction.
    Eur Heart J. 2020 Jan 3. pii: 5695525. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2019
21. PAVASINI R, Biscaglia S, Barbato E, Tebaldi M, et al
    Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials.
    Eur Heart J. 2019 Dec 31. pii: 5692630. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. LANCINI D, Shetty R
    Tension pneumothorax: a Brugada phenocopy and ST-elevation myocardial infarction mimic.
    Eur Heart J. 2019 Dec 28. pii: 5688935. doi: 10.1093.
    PubMed    
    
    
    
23. WELSH RC
    Applying evidence-based antiplatelet therapy in patients following a myocardial infarction without percutaneous coronary revascularization.
    Eur Heart J. 2019 Dec 23. pii: 5686009. doi: 10.1093.
    PubMed    
    
    
    
24. ROEVER L, Tse G, Versaci F, Biondi-Zoccai G, et al
    Admission glucagon-like peptide-1 levels in acute myocardial infarction: is this a new biomarker of cardiovascular risk?
    Eur Heart J. 2019 Dec 13. pii: 5675546. doi: 10.1093.
    PubMed    
    
    
    
25. KALLA M, Hao G, Tapoulal N, Tomek J, et al
    The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.
    Eur Heart J. 2019 Dec 13. pii: 5675548. doi: 10.1093.
    PubMed     Abstract available
    
    
    
26. FURTADO RHM, Nicolau JC, Magnani G, Im K, et al
    Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54.
    Eur Heart J. 2019 Dec 7. pii: 5663567. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. BHARADWAJ A, Potts J, Mohamed MO, Parwani P, et al
    Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA.
    Eur Heart J. 2019 Dec 4. pii: 5652220. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2019
28. RIMBERT A, Dalila N, Wolters JC, Huijkman N, et al
    A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor.
    Eur Heart J. 2019 Oct 19. pii: 5599853. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. KAHLES F, Ruckbeil MV, Mertens RW, Foldenauer AC, et al
    Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction.
    Eur Heart J. 2019 Oct 16. pii: 5588525. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2019
30. DANCHIN N, Popovic B, Puymirat E, Goldstein P, et al
    Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme.
    Eur Heart J. 2019 Sep 20. pii: 5572227. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. THRANE PG, Kristensen SD, Olesen KKW, Mortensen LS, et al
    16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.
    Eur Heart J. 2019 Sep 2. pii: 5554441. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. MUKHERJEE D
    Tailoring strategies to optimize ischaemic benefit vs. bleeding risk in individuals post-myocardial infarction.
    Eur Heart J. 2019 Sep 1. pii: 5555736. doi: 10.1093.
    PubMed    
    
    
    
33. SIMONSSON M, Wallentin L, Alfredsson J, Erlinge D, et al
    Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry.
    Eur Heart J. 2019 Sep 1. pii: 5554428. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2019
34. CREA F, Montone RA, Niccoli G
    Myocardial infarction with non-obstructive coronary atherosclerosis: dealing with pears and apples.
    Eur Heart J. 2019 Aug 3. pii: 5543490. doi: 10.1093.
    PubMed    
    
    
    July 2019
35. ODER D, Topp MS, Nordbeck P
    Coronary B-cell lymphoma infiltration causing myocardial infarction.
    Eur Heart J. 2019 Jul 31. pii: 5542062. doi: 10.1093.
    PubMed    
    
    
    
36. FRANGOGIANNIS NG
    S100A8/A9 as a therapeutic target in myocardial infarction: cellular mechanisms, molecular interactions, and translational challenges.
    Eur Heart J. 2019 Jul 23. pii: 5537337. doi: 10.1093.
    PubMed    
    
    
    
37. MARINKOVIC G, Grauen Larsen H, Yndigegn T, Szabo IA, et al
    Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction.
    Eur Heart J. 2019 Jul 10. pii: 5530698. doi: 10.1093.
    PubMed     Abstract available
    
    
    
38. THIELE H, Ohman EM, de Waha-Thiele S, Zeymer U, et al
    Management of cardiogenic shock complicating myocardial infarction: an update 2019.
    Eur Heart J. 2019 Jul 4. pii: 5528526. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2019
39. 
    Corrigendum to: Ephemeral Coronary Heart Disease.
    Eur Heart J. 2019 Jun 29. pii: 5530690. doi: 10.1093.
    PubMed    
    
    
    
40. THYGESEN K, Jaffe AS
    Should myocardial infarction type 2 be regarded as two separate entities?
    Eur Heart J. 2019 Jun 26. pii: 5523696. doi: 10.1093.
    PubMed    
    
    
    
41. MESSERLI FH
    Ephemeral Coronary Heart Disease.
    Eur Heart J. 2019;40:1906-1908.
    PubMed    
    
    
    
42. DREYER RP, Tavella R, Curtis JP, Wang Y, et al
    Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population.
    Eur Heart J. 2019 Jun 21. pii: 5521361. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. WHITE HD
    Adjunctive antithrombotic therapy with primary percutaneous coronary intervention in ST elevation myocardial infarction: ATOLL in perspective.
    Eur Heart J. 2019;40:e4-e7.
    PubMed    
    
    
    
44. ZENG L, Ntalla I, Kessler T, Kastrati A, et al
    Genetically modulated educational attainment and coronary disease risk.
    Eur Heart J. 2019 Jun 6. pii: 5512096. doi: 10.1093.
    PubMed     Abstract available
    
    
    
45. LI Z, Solomonidis EG, Meloni M, Taylor RS, et al
    Single-cell transcriptome analyses reveal novel targets modulating cardiac neovascularization by resident endothelial cells following myocardial infarction.
    Eur Heart J. 2019 Jun 4. pii: 5510786. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. ROHDE D, Nahrendorf M
    Clonal and diverse: revisiting cardiac endothelial cells after myocardial infarction.
    Eur Heart J. 2019 Jun 4. pii: 5510784. doi: 10.1093.
    PubMed    
    
    
    May 2019
47. LEMKES JS, Janssens GN, van Royen N
    ST-resolution and spontaneous reperfusion in patients with transient ST-segment elevation myocardial infarction.
    Eur Heart J. 2019 May 29. pii: 5506052. doi: 10.1093.
    PubMed    
    
    
    
48. WHITE HD, Steg PG, Szarek M, Bhatt DL, et al
    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.
    Eur Heart J. 2019 May 23. pii: 5497814. doi: 10.1093.
    PubMed     Abstract available
    
    
    
49. NISHI T, Funabashi N, Fujimoto Y, Kobayashi Y, et al
    Simultaneous anterior and inferior myocardial infarction in a patient with a single coronary artery anomaly.
    Eur Heart J. 2019 May 3. pii: 5485104. doi: 10.1093.
    PubMed    
    
    
    
50. GATZOULIS KA, Tsiachris D, Arsenos P, Antoniou CK, et al
    Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study.
    Eur Heart J. 2019 May 3. pii: 5485105. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2019
51. HU C, Tkebuchava T, Hu D
    Managing acute myocardial infarction in China.
    Eur Heart J. 2019;40:1179-1181.
    PubMed    
    
    
    
52. MEHRAN R, Kalkman DN, Angiolillo DJ
    Atrial fibrillation, with ACS and PCI: walking a tightrope.
    Eur Heart J. 2019 Apr 8. pii: 5431179. doi: 10.1093.
    PubMed    
    
    
    March 2019
53. BEN-YEHUDA O, Chen S, Redfors B, McAndrew T, et al
    Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
    Eur Heart J. 2019 Mar 28. pii: 5421317. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. HERRING N, Tapoulal N, Kalla M, Ye X, et al
    Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction.
    Eur Heart J. 2019 Mar 11. pii: 5374846. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. CHEN K, Breitner S, Wolf K, Hampel R, et al
    Temporal variations in the triggering of myocardial infarction by air temperature in Augsburg, Germany, 1987-2014.
    Eur Heart J. 2019 Mar 11. pii: 5374842. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. YOSHIDA R, Takagi K, Morita Y, Morishima I, et al
    Incidentally discovered left ventricular pseudoaneurysm after silent myocardial infarction occurred in a young woman with peritoneal dialysis.
    Eur Heart J. 2019 Mar 11. pii: 5374728. doi: 10.1093.
    PubMed    
    
    
    
57. SEHESTED TSG, Carlson N, Hansen PW, Gerds TA, et al
    Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction.
    Eur Heart J. 2019 Mar 9. pii: 5372329. doi: 10.1093.
    PubMed     Abstract available
    
    
    
58. REDFORS B, Dworeck C, Haraldsson I, Angeras O, et al
    Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry.
    Eur Heart J. 2019 Mar 9. pii: 5372330. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. RABER L, Yamaji K, Kelbaek H, Engstrom T, et al
    Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial inf
    Eur Heart J. 2019 Mar 9. pii: 5372331. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2019
60. HECHT HS, Shaw L, Chandrashekhar YS, Bax JJ, et al
    Should NICE guidelines be universally accepted for the evaluation of stable coronary disease? A debate.
    Eur Heart J. 2019 Feb 27. pii: 5366197. doi: 10.1093.
    PubMed     Abstract available
    
    
    
61. WITASSEK F, Radovanovic D, Erne P, Puhan M, et al
    Mortality with antidepressants after acute MI: Antidepressant use after acute myocardial infarction (MI) is associated with an increased mortality 1 year after discharge from Swiss hospitals.
    Eur Heart J. 2019;40:410.
    PubMed    
    
    
    January 2019
62. CHEN S, Stone GW
    Circadian influences, time of hospitalization, and prognosis in acute myocardial infarction.
    Eur Heart J. 2019 Jan 30. pii: 5304404. doi: 10.1093.
    PubMed    
    
    
    
63. WU J, Hall M, Dondo TB, Wilkinson C, et al
    Association between time of hospitalization with acute myocardial infarction and in-hospital mortality.
    Eur Heart J. 2019 Jan 29. pii: 5301310. doi: 10.1093.
    PubMed     Abstract available
    
    
    
64. VACCARINO V, Badimon L, Bremner JD, Cenko E, et al
    Depression and coronary heart disease: 2018 ESC position paper of the working group of coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines.
    Eur Heart J. 2019 Jan 28. pii: 5303703. doi: 10.1093.
    PubMed    
    
    
    
65. THYGESEN K
    'Ten Commandments' for the Fourth Universal Definition of Myocardial Infarction 2018.
    Eur Heart J. 2019;40:226.
    PubMed    
    
    
    December 2018
66. LUSCHER TF
    Personalized approaches to heart failure: age, acute presentation, and comorbidities.
    Eur Heart J. 2018;39:4223-4226.
    PubMed    
    
    
    
67. RESOR CD, Bhatt DL
    Bioresorbable vascular scaffolds in acute myocardial infarction: non-inferior or not enough data?
    Eur Heart J. 2018 Dec 18. pii: 5251899. doi: 10.1093.
    PubMed    
    
    
    
68. BYRNE RA, Alfonso F, Schneider S, Maeng M, et al
    Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction
    Eur Heart J. 2018 Dec 5. pii: 5231946. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2018
69. SHARMA S, Malhotra A
    Exercise testing and coronary disease: pushing fitness to higher peaks.
    Eur Heart J. 2018 Nov 29. pii: 5193507. doi: 10.1093.
    PubMed    
    
    
    
70. LETNES JM, Dalen H, Vesterbekkmo EK, Wisloff U, et al
    Peak oxygen uptake and incident coronary heart disease in a healthy population: the HUNT Fitness Study.
    Eur Heart J. 2018 Nov 29. pii: 5193503. doi: 10.1093.
    PubMed     Abstract available
    
    
    
71. XIN Y, Chen X, Hu W
    Oxygen therapy in ST-elevation myocardial infarction.
    Eur Heart J. 2018 Nov 28. pii: 5212709. doi: 10.1093.
    PubMed    
    
    
    
72. POLIMENI A, Spaccarotella C, Mongiardo A, Indolfi C, et al
    Myocardial infarction after dog bite.
    Eur Heart J. 2018 Nov 28. pii: 5212711. doi: 10.1093.
    PubMed    
    
    
    
73. BERGMARK BA, Faxon DP
    Transient ST-segment myocardial infarction: a new category of high risk acute coronary syndrome?
    Eur Heart J. 2018 Nov 15. pii: 5184544. doi: 10.1093.
    PubMed    
    
    
    
74. THYGESEN K
    What's new in the Fourth Universal Definition of Myocardial infarction?
    Eur Heart J. 2018;39:3757-3758.
    PubMed    
    
    
    
75. ELNABAWI YA, Dey AK, Mehta NN
    Emerging Applications of Coronary CT Angiography in Coronary Heart Disease: Getting Better with Time.
    Eur Heart J. 2018;39:3682-3684.
    PubMed    
    
    
    October 2018
76. FARAG M, Spinthakis N, Gue YX, Srinivasan M, et al
    Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study.
    Eur Heart J. 2018 Oct 30. pii: 5149701. doi: 10.1093.
    PubMed     Abstract available
    
    
    
77. LEMKES JS, Janssens GN, van der Hoeven NW, van de Ven PM, et al
    Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial.
    Eur Heart J. 2018 Oct 26. pii: 5145843. doi: 10.1093.
    PubMed     Abstract available
    
    
    
78. KALKMAN DN, Aquino M, Claessen BE, Baber U, et al
    Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions.
    Eur Heart J. 2018 Oct 25. pii: 5144689. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. HERITIER H, Vienneau D, Foraster M, Eze IC, et al
    A systematic analysis of mutual effects of transportation noise and air pollution exposure on myocardial infarction mortality: a nationwide cohort study in Switzerland.
    Eur Heart J. 2018 Oct 24. pii: 5144026. doi: 10.1093.
    PubMed     Abstract available
    
    
    
80. WALLENTIN L
    Different perspectives on outcomes in patients with non-ST-elevation myocardial infarction when observed in clinical trials and in real life.
    Eur Heart J. 2018 Oct 17. pii: 5137113. doi: 10.1093.
    PubMed    
    
    
    September 2018
81. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014.
    Eur Heart J. 2018 Sep 19. pii: 5103432. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. STONE GW, Genereux P, Harrington RA, White HD, et al
    Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHA
    Eur Heart J. 2018 Sep 9. pii: 5093357. doi: 10.1093.
    PubMed     Abstract available
    
    
    
83. HALL M, Bebb OJ, Dondo TB, Yan AT, et al
    Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction.
    Eur Heart J. 2018 Sep 7. pii: 5092654. doi: 10.1093.
    PubMed     Abstract available
    
    
    
84. MONTONE RA, Niccoli G, Lanza GA, Crea F, et al
    Reconsidering aetiologies of type 2 myocardial infarction: when a classification is a simplistic approach for a complex reality.
    Eur Heart J. 2018 Sep 6. pii: 5091846. doi: 10.1093.
    PubMed    
    
    
    
85. NESTELBERGER T, Boeddinghaus J, Mueller C
    Type 2 myocardial infarction.
    Eur Heart J. 2018 Sep 6. pii: 5091844. doi: 10.1093.
    PubMed    
    
    
    August 2018
86. BOEDDINGHAUS J, Nestelberger T, Twerenbold R, Neumann JT, et al
    Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction.
    Eur Heart J. 2018 Aug 29. pii: 5086724. doi: 10.1093.
    PubMed     Abstract available
    
    
    
87. THYGESEN K, Alpert JS, Jaffe AS, Chaitman BR, et al
    Fourth universal definition of myocardial infarction (2018).
    Eur Heart J. 2018 Aug 25. pii: 5079081. doi: 10.1093.
    PubMed    
    
    
    
88. SHIMONO H, Kajiya T, Atsuchi Y, Atsuchi N, et al
    Giant left ventricular pseudo-aneurysm after posterior myocardial infarction.
    Eur Heart J. 2018 Aug 21. pii: 5077320. doi: 10.1093.
    PubMed    
    
    
    
89. POLOVINA M, Hindricks G, Maggioni A, Piepoli M, et al
    Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation.
    Eur Heart J. 2018 Aug 7. pii: 5067645. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2018
90. VARENNE O, Sinnaeve PR
    De-escalation of antiplatelet treatment after percutaneous coronary interventions for acute coronary syndromes: is less more?
    Eur Heart J. 2018 Jul 24. pii: 5057993. doi: 10.1093.
    PubMed    
    
    
    
91. LUSCHER TF
    Performance of modern stents in stable and acute coronary disease.
    Eur Heart J. 2018;39:2435-2438.
    PubMed    
    
    
    June 2018
92. SAITO S, Krucoff MW, Nakamura S, Mehran R, et al
    Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-elu
    Eur Heart J. 2018 Jun 21. pii: 5042208. doi: 10.1093.
    PubMed     Abstract available
    
    
    
93. HOFMANN R, Witt N, Lagerqvist B, Jernberg T, et al
    Oxygen therapy in ST-elevation myocardial infarction.
    Eur Heart J. 2018 Jun 14. pii: 5037999. doi: 10.1093.
    PubMed     Abstract available
    
    
    
94. GARCIA-GARCIA HM, McFadden EP, Farb A, Mehran R, et al
    Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
    Eur Heart J. 2018;39:2192-2207.
    PubMed     Abstract available
    
    
    May 2018
95. MONTONE RA, Niccoli G, Lanza GA, Crea F, et al
    Personalized treatment of myocardial infarction and non-obstructive coronary arteries: an unmet need in a high-risk population.
    Eur Heart J. 2018 May 29. pii: 5020746. doi: 10.1093.
    PubMed    
    
    
    
96. IBANEZ B, Halvorsen S, Roffi M, Bueno H, et al
    Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force.
    Eur Heart J. 2018 May 29. pii: 5020748. doi: 10.1093.
    PubMed    
    
    
    
97. JANSSENS SP, Bogaert J, Zalewski J, Toth A, et al
    Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial.
    Eur Heart J. 2018 May 24. pii: 5003325. doi: 10.1093.
    PubMed     Abstract available
    
    
    
98. RABER L, Mintz GS, Koskinas KC, Johnson TW, et al
    Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions: Endorsed by the Chinese Society of Cardiology.
    Eur Heart J. 2018 May 22. pii: 5001185. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2018
99. MAHMOUD KD, Jolly SS, James S, Dzavik V, et al
    Clinical impact of direct stenting and interaction with thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Thrombectomy Trialists Collaboration.
    Eur Heart J. 2018 Apr 21. pii: 4975836. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2018
100. WALDMANN V, Bougouin W, Karam N, Dumas F, et al
     Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation.
     Eur Heart J. 2018 Mar 16. pii: 4939309. doi: 10.1093.
     PubMed     Abstract available
     
     
     
101. AUFFRET V, Cottin Y, Leurent G, Gilard M, et al
     Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.
     Eur Heart J. 2018 Mar 15. pii: 4938779. doi: 10.1093.
     PubMed     Abstract available
     
     
     
102. DAI J, Xing L, Jia H, Zhu Y, et al
     In vivo predictors of plaque erosion in patients with ST-segment elevation myocardial infarction: a clinical, angiographical, and intravascular optical coherence tomography study.
     Eur Heart J. 2018 Mar 13. pii: 4934156. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2018
103. THYGESEN K, Jaffe AS
     The prognostic impact of periprocedural myocardial infarction and injury.
     Eur Heart J. 2018 Feb 26. pii: 4911112. doi: 10.1093.
     PubMed    
     
     
     
104. QAYYUM F, Lauridsen BK, Frikke-Schmidt R, Kofoed KF, et al
     Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease.
     Eur Heart J. 2018 Feb 23. pii: 4907930. doi: 10.1093.
     PubMed     Abstract available
     
     
     
105. 
     euro6.5 million award to study impact of ECMO on myocardial infarction patients.
     Eur Heart J. 2018;39:649.
     PubMed    
     
     
     
106. WIJNS W, Naber CK
     Reperfusion delay in patients with high-risk ST-segment elevation myocardial infarction: every minute counts, much more than suspected.
     Eur Heart J. 2018 Feb 14. pii: 4855285. doi: 10.1093.
     PubMed    
     
     
     
107. SCHOLZ KH, Maier SKG, Maier LS, Lengenfelder B, et al
     Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.
     Eur Heart J. 2018 Feb 14. pii: 4855284. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2018
108. BERGMARK BA, Scirica BM, Steg PG, Fanola CL, et al
     Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.
     Eur Heart J. 2018 Jan 31. pii: 4831245. doi: 10.1093.
     PubMed     Abstract available
     
     
     
109. ZEITOUNI M, Silvain J, Guedeney P, Kerneis M, et al
     Periprocedural myocardial infarction and injury in elective coronary stenting.
     Eur Heart J. 2018 Jan 20. pii: 4815728. doi: 10.1093.
     PubMed     Abstract available
     
     
     
110. MEHLUM MH, Liestol K, Kjeldsen SE, Julius S, et al
     Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks.
     Eur Heart J. 2018 Jan 20. pii: 4815726. doi: 10.1093.
     PubMed     Abstract available
     
     
     
111. LUSCHER TF
     ST-segment elevation myocardial infarction: the new ESC Guidelines.
     Eur Heart J. 2018;39:75-78.
     PubMed    
     
     
     
112. KIM K, Park SM, Lee K
     Weight gain after smoking cessation does not modify its protective effect on myocardial infarction and stroke: evidence from a cohort study of men.
     Eur Heart J. 2018 Jan 6. pii: 4791953. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2017
113. KOENIG T, Sedding DG, Wester HJ, Derlin T, et al
     Seeing the unseen: post-infarction inflammation in an isolated right ventricular myocardial infarction visualized by combined cardiac magnetic resonance imaging and chemokine receptor CXCR4-targeted molecular imaging.
     Eur Heart J. 2017 Dec 27. pii: 4780241. doi: 10.1093.
     PubMed    
     
     
     
114. MONTONE RA, Niccoli G, Fracassi F, Russo M, et al
     Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests.
     Eur Heart J. 2017 Dec 8. pii: 4710061. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2017
115. KUBO T, Shinke T, Okamura T, Hibi K, et al
     Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results.
     Eur Heart J. 2017;38:3139-3147.
     PubMed     Abstract available
     
     
     
116. LUSCHER TF
     Optimizing percutaneous coronary interventions: Heart Team, SYNTAX II Score, physiology and imaging guidance, modern stents, and guideline-based medication.
     Eur Heart J. 2017;38:3109-3113.
     PubMed    
     
     
     October 2017
117. KIM MK, Han K, Kim HS, Park YM, et al
     Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study.
     Eur Heart J. 2017 Oct 21. doi: 10.1093.
     PubMed     Abstract available
     
     
     
118. THYGESEN K, Jaffe AS
     Detecting myocardial infarction type 2: targetting the right patients.
     Eur Heart J. 2017 Oct 5. doi: 10.1093.
     PubMed    
     
     
     
119. MANIWA N, Fujino M, Nakai M, Nishimura K, et al
     Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarction.
     Eur Heart J. 2017 Oct 3. doi: 10.1093.
     PubMed     Abstract available
     
     
     September 2017
120. LEU HB, Chang HH, Lin SM, Chen YH, et al
     Double trouble for transcatheter aortic valve implantation: a patient with no vascular access and high-risk features for bilateral coronary obstruction.
     Eur Heart J. 2017;38:2787.
     PubMed    
     
     
     
121. KIVIMAKI M, Nyberg ST, Batty GD, Kawachi I, et al
     Long working hours as a risk factor for atrial fibrillation: a multi-cohort study.
     Eur Heart J. 2017;38:2621-2628.
     PubMed     Abstract available
     
     
     August 2017
122. KOJIMA S, Michikawa T, Ueda K, Sakamoto T, et al
     Asian dust exposure triggers acute myocardial infarction.
     Eur Heart J. 2017 Aug 29. doi: 10.1093.
     PubMed     Abstract available
     
     
     
123. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
     Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.
     Eur Heart J. 2017 Aug 29. doi: 10.1093.
     PubMed     Abstract available
     
     
     
124. IBANEZ B, James S, Agewall S, Antunes MJ, et al
     2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European S
     Eur Heart J. 2017 Aug 26. doi: 10.1093.
     PubMed    
     
     
     
125. ESCANED J, Collet C, Ryan N, Luigi De Maria G, et al
     Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
     Eur Heart J. 2017 Aug 26. doi: 10.1093.
     PubMed     Abstract available
     
     
     
126. LASSALE C, Tzoulaki I, Moons KGM, Sweeting M, et al
     Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis.
     Eur Heart J. 2017 Aug 14. doi: 10.1093.
     PubMed     Abstract available
     
     
     
127. RIBEIRO HB, Rodes-Cabau J, Blanke P, Leipsic J, et al
     Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry.
     Eur Heart J. 2017 Aug 14. doi: 10.1093.
     PubMed     Abstract available
     
     
     
128. NEUMANN JT, Sorensen NA, Rubsamen N, Ojeda F, et al
     Discrimination of patients with type 2 myocardial infarction.
     Eur Heart J. 2017 Aug 13. doi: 10.1093.
     PubMed     Abstract available
     
     
     
129. D'ASCENZO F, Iannaccone M, Saint-Hilary G, Bertaina M, et al
     Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients.
     Eur Heart J. 2017 Aug 11. doi: 10.1093.
     PubMed     Abstract available
     
     
     
130. KHAN AR, Golwala H, Tripathi A, Bin Abdulhak AA, et al
     Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis.
     Eur Heart J. 2017 Aug 7. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2017
131. DE WAHA S, Patel MR, Granger CB, Ohman EM, et al
     Relationship between microvascular obstruction and adverse events following primary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials.
     Eur Heart J. 2017 Jul 28. doi: 10.1093.
     PubMed     Abstract available
     
     
     
132. VRANCKX P, Windecker S, Welsh RC, Valgimigli M, et al
     Thrombo-embolic prevention after transcatheter aortic valve implantation.
     Eur Heart J. 2017 Jul 25. doi: 10.1093.
     PubMed     Abstract available
     
     
     
133. HOPEWELL JC, Malik R, Valdes-Marquez E, Worrall BB, et al
     Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke.
     Eur Heart J. 2017 Jul 17. doi: 10.1093.
     PubMed     Abstract available
     
     
     
134. POTHINENI NVK, Subramany S, Kuriakose K, Shirazi LF, et al
     Infections, atherosclerosis, and coronary heart disease.
     Eur Heart J. 2017 Jul 12. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2017
135. ZITTERMANN A, Ernst JB, Prokop S, Fuchs U, et al
     Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily.
     Eur Heart J. 2017 May 12. doi: 10.1093.
     PubMed     Abstract available
     
     
     April 2017
136. SINGH-MANOUX A, Fayosse A, Sabia S, Canonico M, et al
     Atrial fibrillation as a risk factor for cognitive decline and dementia.
     Eur Heart J. 2017 Apr 29. doi: 10.1093.
     PubMed     Abstract available
     
     
     
137. VRANCKX P, Frigoli E, Rothenbuhler M, Tomassini F, et al
     Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation.
     Eur Heart J. 2017;38:1069-1080.
     PubMed     Abstract available
     
     
     
138. GABET A, Danchin N, Juilliere Y, Olie V, et al
     Acute coronary syndrome in women: rising hospitalizations in middle-aged French women, 2004-14.
     Eur Heart J. 2017;38:1060-1065.
     PubMed     Abstract available
     
     
     
139. PALMERINI T, Della Riva D, Benedetto U, Bacchi Reggiani L, et al
     Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
     Eur Heart J. 2017;38:1034-1043.
     PubMed     Abstract available
     
     
     
140. GEBHARD C
     Women and acute coronary syndromes: still up to no good.
     Eur Heart J. 2017;38:1066-1068.
     PubMed    
     
     
     
141. ONUMA Y, Serruys PW
     Freedom from long DAPT signals the demise of the bare-metal stent.
     Eur Heart J. 2017;38:970-973.
     PubMed    
     
     
     
142. CARLSSON M
     The impacts on healthcare when coronary angiography as the reference method for diagnostic accuracy of coronary artery disease is replaced by fractional flow reserve!
     Eur Heart J. 2017;38:999-1001.
     PubMed    
     
     
     March 2017
143. LI XS, Obeid S, Klingenberg R, Gencer B, et al
     Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
     Eur Heart J. 2017;38:814-824.
     PubMed     Abstract available
     
     
     
144. JIA H, Dai J, Hou J, Xing L, et al
     Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study).
     Eur Heart J. 2017;38:792-800.
     PubMed     Abstract available
     
     
     February 2017
145. LYALL DM, Celis-Morales CA, Anderson J, Gill JM, et al
     Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants.
     Eur Heart J. 2017;38:577-583.
     PubMed     Abstract available
     
     
     
146. MORTENSEN MB, Nordestgaard BG, Afzal S, Falk E, et al
     ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.
     Eur Heart J. 2017;38:586-594.
     PubMed     Abstract available
     
     
     
147. DEFILIPPIS AP, Young R, McEvoy JW, Michos ED, et al
     Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern
     Eur Heart J. 2017;38:598-608.
     PubMed     Abstract available
     
     
     
148. SHUN-SHIN MJ, Zheng SL, Cole GD, Howard JP, et al
     Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials.
     Eur Heart J. 2017 Feb 21. doi: 10.1093.
     PubMed     Abstract available
     
     
     
149. MATHUR A, Fernandez-Aviles F, Dimmeler S, Hauskeller C, et al
     The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016.
     Eur Heart J. 2017 Feb 15. doi: 10.1093.
     PubMed    
     
     
     
150. ODAKA Y, Takahashi J, Tsuburaya R, Nishimiya K, et al
     Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries.
     Eur Heart J. 2017;38:489-496.
     PubMed     Abstract available
     
     
     
151. KARAKAS M, Schulte C, Appelbaum S, Ojeda F, et al
     Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study.
     Eur Heart J. 2017;38:516-523.
     PubMed     Abstract available
     
     
     
152. MOTWANI M, Dey D, Berman DS, Germano G, et al
     Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis.
     Eur Heart J. 2017;38:500-507.
     PubMed     Abstract available
     
     
     
153. PRIES AR, Reglin B
     Coronary microcirculatory pathophysiology: can we afford it to remain a black box?
     Eur Heart J. 2017;38:478-488.
     PubMed     Abstract available
     
     
     
154. NIELSEN LH, Botker HE, Sorensen HT, Schmidt M, et al
     Prognostic assessment of stable coronary artery disease as determined by coronary computed tomography angiography: a Danish multicentre cohort study.
     Eur Heart J. 2017;38:413-421.
     PubMed     Abstract available
     
     
     
155. VAN DER VALK FM, Kuijk C, Verweij SL, Stiekema LCA, et al
     Increased haematopoietic activity in patients with atherosclerosis.
     Eur Heart J. 2017;38:425-432.
     PubMed     Abstract available
     
     
     
156. BOURANTAS CV, Jaffer FA, Gijsen FJ, van Soest G, et al
     Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology.
     Eur Heart J. 2017;38:400-412.
     PubMed     Abstract available
     
     
     
157. LEIPSIC J, Blanke P
     Prognostic value of coronary CT angiography: lessons from the West Denmark Cardiac Registry.
     Eur Heart J. 2017;38:422-424.
     PubMed    
     
     
     
158. CIMATO TR
     Persistent stem cell-driven inflammation in patients with prior MI and stroke.
     Eur Heart J. 2017;38:433-435.
     PubMed    
     
     
     December 2016
159. BARTUNEK J, Terzic A, Davison BA, Filippatos GS, et al
     Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
     Eur Heart J. 2016 Dec 23. pii: ehw543. doi: 10.1093.
     PubMed     Abstract available
     
     
     
160. PELLICANO M, De Bruyne B, Toth GG, Casselman F, et al
     Fractional flow reserve to guide and to assess coronary artery bypass grafting.
     Eur Heart J. 2016 Dec 23. pii: ehw505. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2016
161. RYAN N, Escaned J
     Myocardial bridge as a cause of persistent post percutaneous coronary intervention angina identified with exercise intracoronary physiology.
     Eur Heart J. 2016.
     PubMed    
     
     
     October 2016
162. CREA F, Bairey Merz CN, Beltrame JF, Kaski JC, et al
     The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift.
     Eur Heart J. 2016.
     PubMed    
     
     
     
163. ALFONSO F, Rivero F
     Coronary revascularization in diabetic patients with chronic kidney disease.
     Eur Heart J. 2016.
     PubMed    
     
     
     September 2016
164. JORGE C, Hiltrop N, Desmet W
     Heart failure with preserved ejection fraction: blame the veins....
     Eur Heart J. 2016.
     PubMed    
     
     
     
165. KOYAMA M, Yano T, Kikuchi K, Nagahara D, et al
     Lethal heart failure with anti-mitochondrial antibody: an arrhythmogenic right ventricular cardiomyopathy mimetic.
     Eur Heart J. 2016.
     PubMed    
     
     
     August 2016
166. YAMAJI K, Raber L, Zanchin T, Spitzer E, et al
     Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial.
     Eur Heart J. 2016.
     PubMed     Abstract available
     
     
     
167. BABER U, Farkouh ME, Arbel Y, Muntner P, et al
     Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease.
     Eur Heart J. 2016.
     PubMed     Abstract available
     
     
     
168. EISEN A, Cannon CP, Blazing MA, Bohula EA, et al
     The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.
     Eur Heart J. 2016.
     PubMed     Abstract available
     
     
     June 2016
169. HEIDBUCHEL H, Verhamme P, Alings M, Antz M, et al
     Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.
     Eur Heart J. 2016.
     PubMed     Abstract available
     
     
     May 2016
170. PONIKOWSKI P, Voors AA, Anker SD, Bueno H, et al
     2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contributio
     Eur Heart J. 2016.
     PubMed    
     
     
     April 2016
171. MADONNA R, Van Laake LW, Davidson SM, Engel FB, et al
     Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.
     Eur Heart J. 2016.
     PubMed     Abstract available
     
     
     February 2016
172. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
     Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
     Eur Heart J. 2016.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: